Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids

Stopped Repros stopped the study for safety and FDA put the study on hold for safety.

Conditions

• Uterine Fibroids
• Anemia

Interventions

• DRUG: Proellex 25 mg
• DRUG: Proellex 50 mg
• DRUG: Placebo

Sponsor

Repros Therapeutics Inc.